Erlotinib and Bevacizumabversuscisplatin, Gemcitabine and Bevacizumab in Unselected Nonsquamous Nonsmall Cell Lung Cancer

European Respiratory Journal - United Kingdom
doi 10.1183/09031936.00229014
Full Text
Abstract

Available in full text

Date
Authors
Publisher

European Respiratory Society (ERS)

Related search

Bevacizumab in the Treatment of Nonsquamous Non-Small Cell Lung Cancer: Clinical Trial Evidence and Experience

Therapeutic Advances in Respiratory Disease
PulmonaryRespiratory MedicinePharmacology
2016English

TP53 Mutations in Nonsmall Cell Lung Cancer

Journal of Biomedicine and Biotechnology
2011English

Inactivation ofLLC1 Gene in Nonsmall Cell Lung Cancer

International Journal of Cancer
Cancer ResearchOncology
2007English

Thyroid Metastasis From Nonsmall Cell Lung Cancer

Case Reports in Oncological Medicine
Oncology
2013English

Bevacizumab in Small Cell Lung Cancer

Annals of Translational Medicine
Medicine
2017English

Refining the Treatment of Advanced Nonsmall Cell Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2010English

Effectiveness of Maintenance Treatments for Nonsmall Cell Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2011English

Cigarette Smoking Increases Copy Number Alterations in Nonsmall-Cell Lung Cancer

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2011English

Composite Anatomical-Clinical-Molecular Prognostic Model in Nonsmall Cell Lung Cancer

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy